CENTURY THERAPEUTICS INC Share Price Today: Live Updates & Key Insights
CENTURY THERAPEUTICS INC share price today is $2.4642, up -2.81%. The stock opened at $2.52 against the previous close of $2.49, with an intraday high of $2.65 and low of $2.41.
CENTURY THERAPEUTICS INC Share Price Chart
CENTURY THERAPEUTICS INC
CENTURY THERAPEUTICS INC Share Price Performance
CENTURY THERAPEUTICS INC Institutional Holdings
CENTURY THERAPEUTICS INC Market Status
CENTURY THERAPEUTICS INC Fundamentals
Market Cap 434.93 M
PB Ratio 2.7704
PE Ratio 0.0
Enterprise Value 366.77 M
Total Assets 223.70 M
Volume 4989664
CENTURY THERAPEUTICS INC Company Financials
About CENTURY THERAPEUTICS INC & investment objective
Company Information Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candidate is CNTY-813, an iPSC-derived beta islet cell replacement therapy engineered with Allo-Evasion 5.0 for the treatment of type 1 diabetes. The company is also involved in the development of CNTY-308, a CD19-targeted CD4+/CD8+ CAR-iT cell therapy engineered with Allo-Evasion 5.0 as a potential treatment for B-cell-mediated autoimmune diseases; and CNTY-101, an allogeneic, iPSC-derived CAR-iNK cell therapy with six precision gene edits engineered to express CD19 CAR, with Allo-Evasion 1.0 edits designed for the treatment of CD19 for B-cell mediated autoimmune diseases. Century Therapeutics, Inc. was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Organisation Biotechnology
Employees 78
Industry Biotechnology
CEO Dr. Brent Pfeiffenberger M.B.A., Pharm.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
CENTURY THERAPEUTICS INC FAQs
What is the share price of CENTURY THERAPEUTICS INC today?
The current share price of CENTURY THERAPEUTICS INC is $2.4642.
Can I buy CENTURY THERAPEUTICS INC shares in India?
Yes, Indian investors can buy CENTURY THERAPEUTICS INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy CENTURY THERAPEUTICS INC shares in India?
You can easily invest in CENTURY THERAPEUTICS INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy CENTURY THERAPEUTICS INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of CENTURY THERAPEUTICS INC.
Can I buy fractional shares of CENTURY THERAPEUTICS INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of CENTURY THERAPEUTICS INC?
CENTURY THERAPEUTICS INC has a market cap of $434.93 M.
In which sector does CENTURY THERAPEUTICS INC belong?
CENTURY THERAPEUTICS INC operates in the Biotechnology sector.
What documents are required to invest in CENTURY THERAPEUTICS INC stocks?
To invest, you typically need:
What is the PE and PB ratio of CENTURY THERAPEUTICS INC?
The PE ratio of CENTURY THERAPEUTICS INC is N/A and the PB ratio is 2.77.